Patent · US Active

Isoquinolinesulfonyl derivative as RHO kinase inhibitor

US9856264B2 · kind B2 · utility

2Cited by

4References

19Claims

0Family size

Assignee

Medshine Discovery Inc. · CN

Inventors

Lingyun WU · Shanghai, CN
Yuanshan Yao · Shanghai, CN
Zhaoguo Chen · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Apr 21, 2015
Grant date	Jan 2, 2018
Priority date	—
Expiry date	Apr 21, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention discloses a class of isoquinolinesulfonyl derivatives as RHO kinase inhibitors, and pharmaceutical compositions thereof, and relates to pharmaceutically acceptable uses thereof. Specifically, the present invention relates to a compound as represented by formula (I), or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.